Japan Approves Lynparza, Abiraterone for BRCA-Mutated Prostate Cancer

miragenews.com

9 months ago

AstraZeneca and MSD's Lynparza (olaparib) in combination with abiraterone and prednisolone has been approved in Japan for the treatment of adult